Thompson Siegel & Walmsley’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Thompson Siegel & Walmsley’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-505,024	Closed	-$485K	–	562
2023 Q2	$485K	Buy	+505,024	New	+$499K	0.01%	301

Thompson Siegel & Walmsley's SPPI Position: Q3 2023 in Review

Thompson Siegel & Walmsley sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 505,024 shares — an estimated $485K sold.

Thompson Siegel & Walmsley first reported a position in SPPI in Q2 2023 and held it in 1 quarter. The position peaked at $485K in Q2 2023. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

Thompson Siegel & Walmsley reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
Thompson Siegel & Walmsley sold 505,024 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $485K.
Thompson Siegel & Walmsley first reported a position in Spectrum Pharmaceuticals Inc in Q2 2023 and held it in 1 quarter.
Thompson Siegel & Walmsley's Spectrum Pharmaceuticals Inc position peaked at $485K in Q2 2023.
0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2023, filed 8 Nov 2023.